Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Dicerna Pharmaceuticals Inc (DRNA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2020 |
GN
| VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors |
| 02/05/2019 |
GN
| Recent Analysis Shows DICK'S Sporting Goods, Zix, Q2, InfraREIT, The Boston Beer, and Dicerna Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth |
| 11/30/2018 |
GN
| Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture — Research Highlights Growth, Revenue, and Consolidated Results |
| 08/29/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications |
| 07/25/2018 |
GN
| Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals — Future Expectations, Projections Moving into 2018 |
| 05/18/2018 |
GN
| Research Report Identifies Carolina Financial, Dicerna Pharmaceuticals, On Assignment, Digimarc, CIRCOR International, and Nordson with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 01/24/2018 |
GN
| Analysis: Positioning to Benefit within Ferroglobe, Corbus Pharmaceuticals, Meritage, Dicerna Pharmaceuticals, Castle Brands, and Ply Gem — Research Highlights Growth, Revenue, and Consolidated Results |
|
|